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In 2021, the three basic pillars of modern cardiac arrest management 
are still high-quality closed chest compressions, early defibrillation of 
shockable rhythms, and prompt recognition and treatment of potential 
reversible causes of cardiac arrest. The reversible causes are commonly 
known and taught as the ‘Hs and Ts’, namely hypovolaemia, hypo/
hyperkalaemia, hydrogen-ion/acidosis, hypoxaemia, hypothermia, 
thrombosis (coronary), thrombosis (pulmonary), tamponade, tension 
pneumothorax, and lastly toxins.[1,2] Walter Kloeck[3] described a 
popular, practical 10-step approach using a zig-zag technique during 
examination to find these reversible causes.
Although the above list serves as a good overview of reversible 
causes, few interventions can quickly and effectively reverse most of 
the conditions. For example, coronary thrombosis can be treated with 
percutaneous coronary intervention (PCI), but in the patient who 
has a refractory life-threatening arrhythmia, some form of therapy 
is needed to preserve circulatory function and haemodynamic status 
while PCI is performed. In the case of hyperkalaemia complicated by 
cardiac dysrhythmia, emergency dialysis is a very effective therapy, 
but once again limited by time as a major factor. A life-sustaining 
‘bridge to therapy’ is needed until the underlying cause can be 
reversed or treated.
Extracorporeal membrane oxygenation (ECMO) is by no means a 
new therapy, with John Gibbon having used it as early as the 1950s. [4] 
Since 2009, its use has gained renewed interest, mostly because the 
H1N1 epidemic has resulted in large numbers of patients with acute 
respiratory distress syndrome requiring more advanced modes of 
oxygenation than just mechanical ventilation.[5] Improved technology 
allowed bedside implementation, resulting in an overall safer, simpler 
intervention, with fewer complications and avoiding the need for a 
dedicated ECMO specialist or perfusionist to look after the ECMO 
circuit. In 2009, a UK-based multicentre randomised controlled 
trial studying the efficacy and economic assessment of conventional 
ventilatory support v. extracorporeal membrane oxygenation for 
severe adult respiratory failure, known as the CESAR trial, provided 
the first piece of evidence supporting the use of extracorporeal life 
support (ECLS) in respiratory failure.[6] More recently, in 2018, the 
ECMO to Rescue Lung Injury in Severe ARDS (EOLIA) randomised 
controlled trial strengthened the evidence supporting the use of 
ECLS.[7] Subsequent analysis of EOLIA indicated an 11% absolute 
mortality reduction with timeous institution of ECMO.[8] ECLS is 
the application of this advanced modality not only in respiratory 
failure, but also as a mode of cardiovascular or haemodynamic 
support, although the two terms are at times erroneously used 
interchangeably.[9] Its use is well established in high-income parts 
of the world such as North America, Europe and Australasia, where 
increasing literature is being published on its application in refractory 
cardiac arrest.[10] At the forefront of implementation, extracorporeal 
cardiopulmonary resuscitation (eCPR) is frequently performed in 
the prehospital setting in Paris, France, where this highly specialised 
application has been pioneered with favourable success rates.[11]
In South Africa (SA), ECLS is only performed in a handful of 
specialised centres, with Swanevelder and Firmin’s[12] local review 
article serving as an up-to-date overview of ECLS as a technique in 
general. Even in these highly specialised centres, the actual number 
of patients receiving ECLS remains low. The authors postulate that 
this is mostly due to a variety of factors such as a knowledge gap 
regarding available therapy, funding difficulty, late referral of suitable 
patients, paucity of local expertise, and lack of local evidence to 
support its use.[12] According to our best knowledge, no reports of 
emergency ECLS implementation in the emergency department (ED) 
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for refractory cardiac arrest in SA and Africa have been published to 




A middle-aged woman was brought to the ED in the late afternoon 
by the local advanced life support emergency medical service (EMS). 
She was initially reported as a post-ictal patient, with no apparent 
threat to life when the EMS arrived. During transport to hospital she 
suffered a witnessed generalised tonic-clonic convulsion, which was 
terminated with 4 mg intravenous lorazepam. During EMS handover 
in the ED, the patient’s level of consciousness deteriorated rapidly, 
without apparent seizure activity, and an advanced airway was placed 
in order to protect the airway during primary survey. Rapid-sequence 
intubation using propofol (1 mg/kg) and rocuronium (1.2 mg/kg) 
was uneventful, with successful placement of a size 7.5 endotracheal 
tube on the first attempt with waveform capnography confirming 
correct placement.
The patient’s first cardiac arrest occurred 5 minutes after 
intubation, due to a non-perfusing dysrhythmia (polymorphic 
ventricular tachycardia). Standard advanced life support measures 
and cardiopulmonary resuscitation (CPR) ensued, with prompt 
conversion to sinus rhythm after a 200 J biphasic electrical 
cardioversion using adhesive pads placed in the anterolateral position. 
Initial blood chemistry revealed hypokalaemia (2.3 mmol/L) as well 
as hyperlactataemia (18 mmol/L). The patient subsequently suffered 
loss of cardiac output and again responded to defibrillation and high-
quality CPR. Further interventions included intravenous lignocaine, 
potassium correction and magnesium sulphate administration for 
arrhythmia management. A 12-lead electrocardiogram obtained 
during a period of return of spontaneous circulation showed no 
obvious acute myocardial infarction as a cause of arrest.
After the patient’s 8th cardiac arrest and limited response to 
corrected electrolyte abnormalities, the ECMO team was consulted, 
comprising a cardiothoracic surgeon with significant experience 
in ECMO cannulation and an ECMO intensivist. They agreed that 
emergency ECLS was a reasonable intervention. Bedside ultrasound 
in the form of the rapid ultrasound for shock and hypotension (RUSH) 
protocol showed no other abnormalities or cause of cardiac arrest.[13] 
After a total of 12 defibrillations, cannulation was performed using a 
femoral approach with the venous (drainage) cannula inserted into 
the right groin and the arterial (return) cannula into the left groin, 
and ECLS was instituted using the Novalung iLA device (Novalung 
GmbH, Germany).
The patient was transferred to the intensive care unit, where she 
remained on both inotropic and ECLS support. Subsequent coronary 
angiography revealed no coronary atherosclerosis, and ECLS was 
successfully weaned during the 4th day. The patient was discharged 
neurologically intact (cerebral performance category (CPC) 1) after 
a total stay of 10 days. It was later concluded that she had ingested 
a large number of caffeine tablets, which accounts for the specific 
toxidrome of refractory dysrhythmias and profound electrolyte 
derangements. Although important for explaining the presentation, 
we consider that this would not have altered therapy if it had been 
known during resuscitation, as initial therapy was directed towards 
correcting the abnormalities. Literature regarding application of 
ECLS in the context of cardiac arrest due to toxin ingestion remains 
sparse, with single published case reports. In one reported case 
cardiac arrest was due to ingestion of diphenhydramine (a first-
generation antihistamine), and in another to severe cardiogenic 
shock after ingestion of disopyramide (a class 1a anti-arrhythmic 
agent).[14,15]
Case 2
A man in his 5th decade of life presented via private transport to the 
ED, complaining of severe chest pain. During triage, he collapsed and 
was immediately moved to the resuscitation area. He was found to be 
pulseless due to ventricular fibrillation and was immediately treated 
with prompt CPR and 200 J biphasic defibrillation. An advanced 
airway in the form of a laryngeal mask was placed to ensure adequate 
oxygenation and to monitor end-tidal carbon dioxide (EtCO2) for 
effectiveness of resuscitation. After delivery of the third defibrillation 
with no effect, refractory ventricular fibrillation was suspected and 
the ECMO team was alerted.
During resuscitation, the laryngeal mask was exchanged for a 
cuffed endotracheal tube while effective manual CPR (evidenced by 
persistent EtCO2 readings >20 mmHg) was underway. The patient 
also received 300 mg amiodarone intravenously, with no effect. 
While resuscitation continued, and evaluation and preparation were 
underway for cannula insertion, an arterial blood gas sample showed 
severe metabolic acidosis (pH 6.8) with no offending electrolyte 
abnormalities. The patient also received 100 mL sodium bicarbonate 
8.5%.
Cannulation was undertaken using a femoral percutaneous 
technique, and within 50 minutes after the witnessed arrest the 
patient was successfully initiated on ECLS, with the cardiac rhythm 
remaining in ventricular fibrillation. Owing to the history of chest 
pain and sudden collapse, he was transferred directly to the cardiac 
catheterisation laboratory for a presumed coronary occlusion. Here 
it was found that the proximal left anterior descending artery 
was occluded, and revascularisation with stenting was successfully 
performed. ECLS was continued for 4 days while the patient’s cardiac 
function gradually recovered. He was discharged after 3 weeks in 
hospital with excellent cognitive function (CPC 1).
This patient presented with an electrical storm, an almost 
universally lethal entity. Boehm et al.[16] described the first case of 
an electrical storm in which dual-axis defibrillation and esmolol 
administration were successfully used in restoring a perfusing 
rhythm. It is important to note that dual-axis defibrillation falls 
outside the current recommendations and esmolol is not widely 
available in SA, and this method may therefore have limited utility 
unless better evidence become available.[2]
Discussion
The American Heart Association refers to the ‘chain of survival’ both 
for in-hospital and out-of-hospital cardiac arrest in their guidelines 
for cardiac arrest management.[2] The most important links and steps 
needed to ensure survival from cardiac arrest are listed in Table 1.
Referring to Table 1, it can be argued that ECLS fits into both 
the advanced resuscitation and post-cardiac arrest links. In low- to 
middle-income countries (LMICs), including SA, it would be unwise 
Table 1. Chain of survival










IHCA = in-hospital cardiac arrest; OHCA = out-of-hospital cardiac arrest; CPR = cardiopulmonary resuscitation.
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to actively advocate ECLS as a treatment priority, as numerous 
barriers, including a lack of basic, context-specific and appropriate 
strategy to address out-of-hospital cardiac arrest, exist. Some of the 
current studied barriers and challenges are: 
• Poor physical access to emergency hospital care provided by the 
public sector in sub-Saharan Africa[17]
• Lack of basic coronary care, as many South Africans still do not 
have access to primary PCI for ST-elevated acute myocardial 
infarction[18]
• Suboptimal CPR performance by emergency providers, e.g. 
Veronese et al.[19] identified that SA intermediate-level emergency 
medical providers performed poorly during a simulated cardiac 
arrest study, owing to a major knowledge and skills gap[19]
• Lack of local legislation promoting public access to automatic 
external defibrillators
• Lack of local legislation promoting layperson training and 
empowerment, with a major opportunity existing to incorporate 
basic CPR training as part of the national basic education 
curriculum.
As mentioned in the introductory paragraphs, doctors involved in 
resuscitation care are often faced with scenarios where a patient 
shows no response to standard resuscitation measures, or even, in 
the case of a reversible cause, where definitive therapy addressing the 
underlying cause is not instantaneously effective, and not appropriate 
in the resuscitation phase. A temporising measure addressing vital 
functions such as adequate perfusion and oxygenation would be ideal 
and therefore perceived to confer some survival benefit. Although it 
is classically reserved as a component of rescue therapy in critical 
care, authors such as Mosier et al.[20] describe the initiation of ECLS 
specifically in the ED both in cardiac arrest and non-cardiac arrest 
scenarios. eCPR as rescue therapy for out-of-hospital cardiac arrest 
is growing in popularity in high-income countries, with several case 
reports and practice recommendations advocating its use.[10,11,21] In 
situations where the first links in the chain of survival have been 
adequately addressed and are effective, ECLS as an advanced form 
of resuscitation would seem to have value in selected instances. The 
immense challenges with implementing an ECLS programme in 
LMICs have been described by Elahi et al.[22] Even with the existence 
and prompt availability of ECLS, selection of patients who will have 
favourable outcomes with no/minimal disability remains an area 
of active study. Current practice recommendations[10] indicate that 
selection should be limited to: 
• Patients with a witnessed cardiac arrest with immediate/bystander 
CPR
• Patients with a high chance of having potentially reversible 
aetiology
• Situations in which ECLS is achievable within 60 minutes of arrest
• Patients who exhibit any sign of life (spontaneous respiration, pupil 
response, etc.).
Retrospectively, both patients described in the present case study were 
correctly selected, as ECLS enabled them to have adequate perfusion 
and oxygenation in the form of artificial circulation despite ongoing 
cardiac arrest. Corrective therapy to address the underlying cause was 
instituted, and ultimately the patients had favourable neurological 
outcomes despite prolonged cardiac arrest. Although ECPR is not 
ready for prime time yet in SA owing to financial and systemic 
constraints, it is exciting to witness a new frontier in advanced 
resuscitation developing, and we believe that all emergency medicine 
personnel should be aware of this emerging form of therapy.
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